Recursion Pharmaceuticals(RXRX)
Focus: Recursion Pharmaceuticals is a public biotech company specializing in automated, software-based drug discovery using AI and phenotypic screening platforms. The company is pre-revenue from drug candidates but positioned as a platform-stage biotech with expanding clinical programs across oncology and rare genetic diseases.
Profile data last refreshed 5h ago · AI intelligence enriched 1mo ago
Funding Stage
PUBLIC
Open Jobs
9-3 this month
Stable — net -3 jobs in 30d
6 added, 9 removed. Backfill posture.
Should You Work at Recursion Pharmaceuticals?
AI assessmentStrong fit for scientists seeking early-stage drug discovery innovation and platform ownership, but careers here depend heavily on belief in the AI platform thesis and tolerance for multi-year pre-approval uncertainty.
Why Work Here
- Cutting-edge AI/ML drug discovery platform — opportunity to work at the intersection of computational biology and traditional pharma, a rare skill intersection
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Early-stage
10 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$45M
Pipeline & Clinical Trials
PHASE_1
Clinical Trials (1)
NCT06980116Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies
Phase 1Help build intelligence for Recursion Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.